Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Med Care. 1999 Apr;37(4 Suppl Lilly):AS67-76.

A framework for drug utilization evaluation in depression: insights from outcomes research.

Author information

  • 1Global Health Economics Research, Eli Lilly and Company, Indianapolis, IN 46285, USA.

Abstract

BACKGROUND:

Drug utilization evaluation (DUE) offers the prospect of improving the quality of care in depression by focusing on drug-related problems (DRPs). Outcomes research in depression can provide a basis on which to address difficulties in implementing DUE programs in the outpatient environment of managed care.

OBJECTIVE:

The purpose of this paper is to facilitate the development of a drug utilization evaluation program for depressed patients receiving care in an outpatient environment.

METHODS:

The literature was reviewed in the area of depression treatment, drug-related problems, and current outcomes research. This information was synthesized into a framework with potential DUE criteria.

CONCLUSION:

The quality of care for depression can be improved if these efforts are focused on solving DRPs. Outcomes research findings may be used as the basis for developing DUE criteria and as a first step in selecting and targeting interventions.

PMID:
10217394
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk